Largest pharmaceutical companies in the United States by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 36 pharmaceutical companies in the United States ranked by revenue, at HUF 32.03T, ahead of Eli Lilly (HUF 22.16T) and Merck & Co (HUF 22.11T). Figures as of 21 Nov 2026, 03:09 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 36
- First
- Johnson & JohnsonHUF 32.03T
- Median
- HUF 469.2B
- Combined market value
- HUF 1270.21T
- Countries
- 1
- Not ranked
- 8no revenue on file
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | HUF 32.03T | HUF 221.4T | HUF 91,967.91 | 1.25% up | 31% up | ||
| 2 | Eli LillyLLY · Health Care | HUF 22.16T | HUF 408.01T | HUF 458,057.81 | 0.30% down | 28% up | ||
| 3 | Merck & CoMRK · Health Care | HUF 22.11T | HUF 112.09T | HUF 45,468.81 | 0.69% up | 36% up | ||
| 4 | PfizerPFE · Health Care | HUF 21.28T | HUF 53.1T | HUF 9,316.82 | 0.51% down | 10% up | ||
| 5 | AbbVieABBV · Health Care | HUF 20.8T | HUF 172.02T | HUF 97,316.59 | 0.94% up | 20% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | HUF 16.39T | HUF 40.87T | HUF 19,993.76 | 0.79% up | 26% up | ||
| 7 | Abbott LaboratoriesABT · Health Care | HUF 15.07T | HUF 60.66T | HUF 35,023.09 | 0.84% down | 19% down | ||
| 8 | Regeneron PharmaceuticalsREGN · Health Care | HUF 4.88T | HUF 32.39T | HUF 313,062.22 | 0.19% down | 22% up | ||
| 9 | ViatrisVTRS · Health Care | HUF 4.86T | HUF 7.65T | HUF 6,674.79 | 1.26% down | 90% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | HUF 4.08T | HUF 44.4T | HUF 175,122.25 | 1.08% down | 22% up | ||
| 11 | ZoetisZTS · Health Care | HUF 3.22T | HUF 10.93T | HUF 26,899.77 | 2.08% down | 34% down | ||
| 12 | Elanco Animal HealthELAN · Health Care | HUF 1.6T | HUF 4.37T | HUF 8,752.37 | 2.09% down | 18% up | ||
| 13 | Alnylam PharmaceuticalsALNY · Health Care | HUF 1.26T | HUF 6.55T | HUF 48,903.11 | 2.71% down | 66% down | ||
| 14 | BioMarin PharmaceuticalBMRN · Health Care | HUF 1.1T | HUF 3.98T | HUF 20,541.21 | 1.64% down | 12% up | ||
| 15 | United TherapeuticsUTHR · Health Care | HUF 1.08T | HUF 8.03T | HUF 188,624.84 | 0.78% down | 18% up | ||
| 16 | Amneal PharmaceuticalsAMRX · Health Care | HUF 1.03T | HUF 2.5T | HUF 7,181.43 | 1.26% down | 79% up | ||
| 17 | Royalty PharmaRPRX · Health Care | HUF 808.7B | HUF 13.38T | HUF 23,275.05 | 1.08% up | 74% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | HUF 588.5B | HUF 1.6T | HUF 19,184.49 | 3.27% down | 26% down | ||
| 19 | Legend BiotechLEGN · Health Care | HUF 349.9B | HUF 1.01T | HUF 5,185.46 | 5.28% down | 43% down | ||
| 20 | Madrigal PharmaceuticalsMDGL · Health Care | HUF 325.9B | HUF 2.99T | HUF 128,905.37 | 4.45% down | 28% down | ||
| 21 | Ionis PharmaceuticalsIONS · Health Care | HUF 320.9B | HUF 1.51T | HUF 9,038.00 | 2.35% down | 64% down | ||
| 22 | Corcept TherapeuticsCORT · Health Care | HUF 258.9B | HUF 2.37T | HUF 21,632.71 | 2.09% down | 16% down | ||
| 23 | Axsome TherapeuticsAXSM · Health Care | HUF 217.1B | HUF 2.31T | HUF 43,986.28 | 4.66% down | 9% down | ||
| 24 | TG TherapeuticsTGTX · Health Care | HUF 209.6B | HUF 3.26T | HUF 21,537.50 | 2.37% down | 103% up | ||
| 25 | InsmedINSM · Health Care | HUF 206.2B | HUF 10.54T | HUF 48,056.44 | 2.17% down | 27% down | ||
| 26 | Mirum PharmaceuticalsMIRM · Health Care | HUF 177.3B | HUF 2.13T | HUF 32,687.08 | 0.65% up | 35% up | ||
| 27 | BridgeBio PharmaBBIO · Health Care | HUF 170.7B | HUF 5.04T | HUF 25,852.48 | 2.75% down | 15% up | ||
| 28 | Travere TherapeuticsTVTX · Health Care | HUF 166.9B | HUF 1.53T | HUF 15,981.41 | 2.69% down | 39% up | ||
| 29 | Arrowhead PharmaceuticalsARWR · Health Care | HUF 153.3B | HUF 1.99T | HUF 14,067.04 | 5.22% down | 8% up | ||
| 30 | Ligand PharmaceuticalsLGND · Health Care | HUF 91.2B | HUF 1.95T | HUF 97,537.61 | 0.03% down | 44% up | ||
| 31 | Rhythm PharmaceuticalsRYTM · Health Care | HUF 64.5B | HUF 2.65T | HUF 38,205.77 | 3.80% down | 15% up | ||
| 32 | CytokineticsCYTK · Health Care | HUF 29.9B | HUF 2.41T | HUF 17,266.72 | 1.32% down | 21% down | ||
| 33 | Protagonist TherapeuticsPTGX · Health Care | HUF 15.6B | HUF 2.69T | HUF 41,279.64 | 2.11% down | 45% up | ||
| 34 | Dianthus TherapeuticsDNTH · Health Care | HUF 692.3M | HUF 1.62T | HUF 28,749.54 | 0.33% down | 105% up | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | HUF 0 | HUF 3.02T | HUF 31,782.60 | 4.26% down | 302% up | ||
| 36 | Praxis Precision MedicinesPRAX · Health Care | HUF 0 | HUF 2.86T | HUF 102,155.21 | 3.37% down | 83% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-21); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 340.0 HUF). 8 companies have no revenue on file and are not ranked here.
Questions and answers
Which pharmaceutical companies in the United States rank first by revenue?
Johnson & Johnson (HUF 32.03T), Eli Lilly (HUF 22.16T) and Merck & Co (HUF 22.11T) are the top three of the 36 pharmaceutical companies in the United States ranked by revenue as of 21 Nov 2026, 03:09 UTC.
How many pharmaceutical companies in the United States are in this ranking?
36 are ranked by revenue. 8 more have no revenue on file and are left out rather than ranked at zero.
What are these pharmaceutical companies in the United States worth together?
The 36 pharmaceutical companies in the United States ranked by revenue have a combined market value of HUF 1270.21T as of 21 Nov 2026, 03:09 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by revenue”, data as of 21 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.